Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
36.20 8.43 years in the IGB + semaglutide group, p = 0.803)
Frequently Asked Questions About Pharmaceutical Compounding
It acts on two pathways (GIP and GLP-1) rather than one, and in the published head-to-head trial data tirzepatide produced greater average weight loss than semaglutide
Current knowledge indicates that astrocytes are critical for some cellular processes, such as the development and/or maintenance of bloodbrain barrier characteristics, the promotion of neurovascular coupling, the attraction of cells through the release of chemokines, K + buffering, release of gliotransmitters, release of glutamate by calcium signaling, maintenance of general metabolism, control of the brain pH, metabolization of dopamine and other substrates by monoamine oxidases (MAOs